Entries by hearten

UEG 2019

UEG Week Barcelona 2019 Barcelona, Spain 21-23 October 2019

EASD 2019

European Association for the Study of Diabetes Barcelona, Spain 16-20 September 2019

Enthera, the first spin-off of BiovelocITA, completed €4 million seed-expansion financing

Enthera, an innovative Italian start-up dedicated to the research and development of innovative therapeutics to treat Type 1 Diabetes and gastrointestinal diseases, received an investment of €4 million led by Sofinnova along with the JDRF T1D Fund (the venture capital fund of the authoritative US JDRF Foundation dedicated to promoting research on Type 1 Diabetes), the accelerator BiovelocITA and its shareholders.

BiovelocITA, the Italian biotech accelerator, launches two companies, one against diabetes, the other against cancer

Two research project collaborations – one in diabetes and one in oncology – have been launched, with a total investment of €2.5 million. These are the first projects launched by BiovelocITA, the Italian biotech accelerator launched last year by the chemist and entrepreneur Silvano Spinelli, Gabriella Camboni and the venture capital firm Sofinnova Partners.